Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023
16 Outubro 2023 - 5:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will report financial results
for the third quarter of 2023 after market close on Monday,
November 6, 2023. Company management will be webcasting a
corresponding conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.guardanthealth.com. The
webcast will be archived and available for replay after the
event.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on helping conquer cancer globally through use of its proprietary
tests, vast data sets and advanced analytics. The Guardant Health
oncology platform leverages capabilities to drive commercial
adoption, improve patient clinical outcomes and lower healthcare
costs across all stages of the cancer care continuum. Guardant
Health has commercially launched Guardant360®, Guardant360 CDx,
Guardant360 TissueNext™, Guardant360 Response™, and
GuardantINFINITY® tests for advanced stage cancer, and Guardant
Reveal™ for early-stage cancer. The Guardant Health screening
portfolio, including the commercially launched Shield™ test, aims
to address the needs of individuals eligible for cancer screening.
For more information, visit guardanthealth.com and follow the
company on LinkedIn and X (Twitter).
Source: Guardant Health, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231016103694/en/
Investor Contact: investors@guardanthealth.com
Media Contact: Melissa Marasco press@guardanthealth.com
+1 650-647-3711
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024